Metropolitan Life Insurance Company (MetLife)’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-8,040
Closed -$1.74M 2685
2021
Q4
$1.74M Sell
8,040
-142
-2% -$30.7K 0.02% 613
2021
Q3
$1.51M Sell
8,182
-269
-3% -$49.7K 0.02% 674
2021
Q2
$1.52M Buy
8,451
+50
+0.6% +$8.97K 0.02% 707
2021
Q1
$1.41M Buy
8,401
+452
+6% +$75.6K 0.02% 735
2020
Q4
$1.21M Sell
7,949
-207
-3% -$31.4K 0.02% 764
2020
Q3
$824K Sell
8,156
-365
-4% -$36.9K 0.01% 861
2020
Q2
$1.03M Sell
8,521
-3,148
-27% -$381K 0.02% 724
2020
Q1
$1.11M Sell
11,669
-634
-5% -$60.1K 0.02% 627
2019
Q4
$1.08M Buy
12,303
+82
+0.7% +$7.22K 0.02% 848
2019
Q3
$975K Sell
12,221
-283
-2% -$22.6K 0.02% 869
2019
Q2
$976K Buy
12,504
+26
+0.2% +$2.03K 0.02% 911
2019
Q1
$1.46M Buy
12,478
+16
+0.1% +$1.88K 0.03% 659
2018
Q4
$1.36M Buy
12,462
+45
+0.4% +$4.9K 0.03% 628
2018
Q3
$1.59M Sell
12,417
-125
-1% -$16K 0.03% 651
2018
Q2
$1.42M Buy
12,542
+72
+0.6% +$8.15K 0.02% 736
2018
Q1
$1.4M Buy
12,470
+99
+0.8% +$11.1K 0.02% 734
2017
Q4
$1.83M Sell
12,371
-28,485
-70% -$4.21M 0.02% 599
2017
Q3
$4.79M Sell
40,856
-1,542
-4% -$181K 0.03% 605
2017
Q2
$5.5M Buy
42,398
+29
+0.1% +$3.76K 0.04% 516
2017
Q1
$5.74M Buy
42,369
+2,199
+5% +$298K 0.04% 500
2016
Q4
$5.76M Sell
40,170
-1,139
-3% -$163K 0.04% 483
2016
Q3
$4.88M Sell
41,309
-1,149
-3% -$136K 0.04% 548
2016
Q2
$4.5M Sell
42,458
-789
-2% -$83.6K 0.03% 578
2016
Q1
$4.82M Buy
43,247
+927
+2% +$103K 0.04% 537
2015
Q4
$6.63M Buy
42,320
+334
+0.8% +$52.3K 0.05% 357
2015
Q3
$5.51M Sell
41,986
-933
-2% -$122K 0.04% 456
2015
Q2
$7.47M Buy
+42,919
New +$7.47M 0.05% 357
2015
Q1
Sell
-42,375
Closed -$5.49M 2443
2014
Q4
$5.49M Buy
42,375
+636
+2% +$82.4K 0.04% 497
2014
Q3
$5.37M Buy
41,739
+2,777
+7% +$357K 0.04% 466
2014
Q2
$3.45M Sell
38,962
-1,678
-4% -$148K 0.02% 733
2014
Q1
$3.82M Buy
40,640
+917
+2% +$86.2K 0.03% 666
2013
Q4
$4.49M Buy
39,723
+374
+1% +$42.3K 0.03% 568
2013
Q3
$3.1M Buy
39,349
+213
+0.5% +$16.8K 0.02% 711
2013
Q2
$2.58M Buy
+39,136
New +$2.58M 0.02% 746